Graft vs Host Disease: all 815 studies

Page 3 of 9. Open to participants first (138), then studies with results posted, then the rest; newest registration first within each.

• Obinutuzumab in cGVHD After Allogeneic Peripheral Blood Stem Cell TransplantationCompletedNCT02867384Phase 2Results posted
• A Study to Evaluate the Safety, Tolerability, and Activity of KD025 in Subjects With Chronic Graft Versus Host DiseaseCompletedNCT02841995Phase 2Results posted
• Study of Baricitinib, a JAK1/2 Inhibitor, in Chronic Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell TransplantationCompletedNCT02759731Phase 1/2Results posted
• Study of ProTmune for Allogeneic HCT in Adult Patients With Hematologic MalignanciesCompletedNCT02743351Phase 1/2Results posted
• A Study of Acute Graft-Versus-Host Disease (GVHD) in Patients Undergoing Allogeneic Stem-Cell TransplantationTerminatedNCT02737306Phase 2Results posted
• rhDNase Eye Drops in Patients With Ocular Graft-Vs.-Host DiseaseTerminatedNCT02702518Phase 1/2Results posted
• Efficacy and Tolerability of Entospletinib in Combination With Systemic Corticosteroids as First-Line Therapy in Adults With Chronic Graft Versus Host Disease (cGVHD)TerminatedNCT02701634Phase 2Results posted
• Sitagliptin for Prevention of Acute Graft Versus-Host Disease After Allogeneic Hematopoietic Stem Cell TransplantationCompletedNCT02683525Phase 2Results posted
• Phase II Trial of Efprezimod Alfa (CD24Fc, MK-7110) for the Prevention of Acute Graft-Versus-Host Disease (GVHD) Following Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) (MK-7110-002)CompletedNCT02663622Phase 2Results posted
• Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHDCompletedNCT02652130Phase 3Results posted
• Gut Decontamination In Pediatric Allogeneic HematopoieticCompletedNCT02641236Phase 2Results posted
• Panobinostat (LBH589): Acute Graft Versus Host Disease (aGVHD) PreventionCompletedNCT02588339Phase 2Results posted
• Study of Pregnyl as Adjunct Therapy for High-Risk or Refractory Acute GVHDCompletedNCT02525029Phase 1/2Results posted
• Methoxsalen and Extracorporeal Photopheresis (ECP) for the Treatment of Pediatric Participants With Steroid Refractory Acute Graft Versus Host DiseaseTerminatedNCT02524847Phase 3Results posted
• Ixazomib Citrate in Treating Patients With Chronic Graft-versus-Host DiseaseCompletedNCT02513498Phase 2Results posted
• Transdermal Patch to Monitor Inflammatory Biomarkers of GVHDCompletedNCT02511782Not applicableResults posted
• Carfilzomib in Treating Patients With Chronic Graft-Versus-Host DiseaseCompletedNCT02491359Phase 2Results posted
• Clinical Study to Investigate the Biological Activity, Safety, Tolerability, and Pharmacokinetics of Ponesimod in Subjects With Symptomatic Chronic GVHDTerminatedNCT02461134Phase 2Results posted
• Study of BEGEDINA® vs "Conventional Treatment" for Treating Steroid-Resistant Acute GvHDTerminatedNCT02411084Phase 3Results posted
• Study of IL-22 IgG2-Fc (F-652) for Subjects With Grade II-IV Lower GI aGVHDCompletedNCT02406651Phase 1/2Results posted
• Early Treatment of Acute Graft Versus Host Disease With Bone Marrow-Derived Mesenchymal Stem Cells and CorticosteroidsTerminatedNCT02379442Phase 1/2Results posted
• Calcineurin Inhibitor-Free Interventions BMT CTN 1301 for Prevention of Graft-versus-Host Disease (BMT CTN 1301)CompletedNCT02345850Phase 3Results posted
• Vismodegib in Treating Patients With Steroid-Refractory Chronic Graft-Versus-Host DiseaseTerminatedNCT02337517Phase 2Results posted
• Biomarkers in Acute Graft-Versus-Host Disease and Extracorporeal Photopheresis Added to Investigator Chosen Therapies of Steroid Refractory Acute GVHDTerminatedNCT02322190Phase 2Results posted
• MLN9708 for the Prophylaxis of Chronic Graft-versus-host Disease in Patient Undergoing Allogeneic TransplantationCompletedNCT02250300Phase 1/2Results posted
• Donor Stem Cell Transplant Followed by Cyclophosphamide in Treating Patients With Hematological DiseasesCompletedNCT02248597Phase 2Results posted
• A Phase 2A Study of ALXN1007 in Participants With Newly Diagnosed Acute Lower Gastrointestinal Graft-Versus-Host DiseaseTerminatedNCT02245412Phase 2Results posted
• Novel Approaches for Graft-versus-Host Disease Prevention Compared to Contemporary Controls (BMT CTN 1203)CompletedNCT02208037Phase 2Results posted
• A Study of Tacrolimus/Methotrexate and Tocilizumab to Prevent Acute Graft-Versus-Host Disease (AGVD) After Allogeneic Hematopoietic Stem Cell TransplantCompletedNCT02206035Phase 2Results posted
• Romidepsin in Treating Patients With Steroid-Refractory Graft-versus-Host DiseaseTerminatedNCT02203578Not applicableResults posted
• Study of the Bruton's Tyrosine Kinase Inhibitor in Subjects With Chronic Graft Versus Host DiseaseCompletedNCT02195869Phase 1/2Results posted
• Bridging Pediatric and Adult Biomarkers in Graft-Versus-Host DiseaseCompletedNCT02194439Results posted
• Safety of Post-transplant Alpha-beta Depleted T-cell Infusion Following Haploidentical Stem Cell Transplant (Haplo SCT)CompletedNCT02193880Not applicableResults posted
• Phase II Trial of Natalizumab + Prednisone for Initial Therapy of Acute GI GVHDCompletedNCT02176031Phase 2Results posted
• Maraviroc as GVHD Prophylaxis in Transplant RecipientsTerminatedNCT02167451Phase 1/2Results posted
• Phase 1/2 Study of Carfilzomib for the Prevention of Relapse and GVHD in Allo-HCT for Hematologic MalignanciesCompletedNCT02145403Phase 1/2Results posted
• Lactobacillus Rhamnosus GG in Reducing Incidence of Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell TransplantCompletedNCT02144701Not applicableResults posted
• Multicenter Study Of Natalizumab Plus Standard Steroid Treatment For High Risk Acute Graft-Versus-Host DiseaseCompletedNCT02133924Phase 2Results posted
• An Open Label Phase II Trial of Topical Sirolimus for the Treatment of Refractory Oral Chronic Graft-versus-Host-DiseaseTerminatedNCT02123966Phase 2Results posted
• Low-Dose Total Lymphoid Irradiation in Treating Patients With Refractory Chronic Graft-versus-Host Disease After Donor Stem Cell TransplantTerminatedNCT02109809Not applicableResults posted
• Nonmyeloablative Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Sickle Cell Disease and Beta-thalassemia in People With Higher Risk of Transplant FailureActive, not recruitingNCT02105766Phase 2Results posted
• Nonmyeloablative Conditioning and Transplantation for Patients With Refractory Systemic Lupus Erythematosus (SLE)TerminatedNCT02080195Phase 1/2Results posted
• Safety and Efficacy Study of R932348 Ophthalmic Solution in Chronic Ocular Graft Versus Host Disease Patients(DROPS-2)CompletedNCT02040623Phase 2Results posted
• Safety and Efficacy of Topical Tacrolimus 0.05% in the Treatment of Ocular Graft-Versus-Host DiseaseCompletedNCT01977781Phase 1Results posted
• A Randomized, Controlled, Double-Masked, Clinical Trial of Autologous Serum Eye Drops for Severe Ocular Chronic Graft-versus-Host Disease (GVHD) in Hematopoietic Stem Cell Transplant (HSCT) PatientsTerminatedNCT01972438Phase 2Results posted
• Abatacept to Treat Steroid Refractory Chronic Graft Versus Host Disease (cGVHD)CompletedNCT01954979Phase 1/2Results posted
• In Vivo Treg Expansion and Graft-Versus-Host Disease ProphylaxisCompletedNCT01927120Phase 2Results posted
• Study of orBec® as Monotherapy in the Treatment of Patients With Upper GI Symptoms Caused by Chronic Graft Versus Host Disease (GVHD)TerminatedNCT01925950Phase 2Results posted
• Vorinostat Plus Tacrolimus & Methotrexate to Prevent Graft vs Host Disease Following Unrelated Stem Cell TransplantCompletedNCT01790568Phase 2Results posted
• Vorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological MalignanciesCompletedNCT01789255Phase 2Results posted
• Standard of Care vs. Bortezomib in Graft-Versus Host Disease After Hematopoietic Stem Cell TransplantCompletedNCT01754389Phase 2Results posted
• Abatacept as GVHD Prophylaxis Phase 2CompletedNCT01743131Phase 2Results posted
• Tacrolimus, Sirolimus and Ustekinumab vs. Tacrolimus and Sirolimus for the Prevention of Acute Graft-Versus-Host DiseaseCompletedNCT01713400Phase 2Results posted
• A Pilot Study of Alpha-1-Antitrypsin (AAT) in Steroid Refractory Acute Graft vs Host DiseaseCompletedNCT01700036Phase 2Results posted
• Treatment of Ocular Graft-versus-Host Disease (GVHD) With Topical Loteprednol Etabonate 0.5%CompletedNCT01695668Not applicableResults posted
• Pomalidomide for Chronic Graft-versus-Host DiseaseCompletedNCT01688466Phase 2Results posted
• Ofatumumab as Primary Therapy of Chronic Graft Versus Host DiseaseCompletedNCT01680965Phase 1/2Results posted
• Atorvastatin as GVHD Prophylaxis for Allogeneic Hematopoietic Cell TransplantationCompletedNCT01665677Phase 2Results posted
• Bandage Lenses in Treating Patients With Ocular Graft-Versus-Host DiseaseCompletedNCT01616056Phase 2Results posted
• Clobetasol for Oral Graft-Versus-Host DiseaseCompletedNCT01557517Phase 2Results posted
• Alpha 1 Anti-Trypsin (AAT) in Treating Patients With Acute Graft-Versus-Host Disease GVHD)CompletedNCT01523821Phase 1/2Results posted
• Safety & Efficacy of Atorvastatin for Prophylaxis of Acute Graft Versus Host Disease in Patients With Hematological Malignancies HLA- Donor Hematopoietic Stem Cell TransplantationCompletedNCT01491958Phase 2Results posted
• Pharmacokinetics-based Mycophenolate Mofetil Dosing for GVHD PreventionCompletedNCT01487577Phase 2Results posted
• Infliximab and Basiliximab for Treatment of Steroid Refractory Acute Graft Versus Host DiseaseTerminatedNCT01485055Phase 2Results posted
• Tocilizumab for Treatment of Steroid Refractory Acute Graft-versus-Host DiseaseTerminatedNCT01475162Phase 1/2Results posted
• In-vivo Regulatory T Cell Enhancement With Cyclophosphamide and SirolimusTerminatedNCT01453140Phase 1/2Results posted
• Cyclophosphamide for Prevention of Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Hematological MalignanciesCompletedNCT01427881Phase 2Results posted
• Comparative Study of Thymosin Beta 4 Eye Drops vs. Vehicle in the Treatment of Severe Dry EyeCompletedNCT01393132Phase 2Results posted
• Extracorporeal Photopheresis (ECP) With Methoxsalen for Chronic Graft Versus Host Disease (cGVHD)CompletedNCT01380535Early Phase 1Results posted
• A Research Study of Bone Marrow Transplantation From Unrelated or Partially Matched Related DonorsCompletedNCT01349101Phase 2Results posted
• Imatinib and Rituximab in Treating Cutaneous Sclerosis in Patients With Chronic Graft-Versus-Host DiseaseCompletedNCT01309997Phase 2Results posted
• Cyclosporine Inhalation Solution (CIS) in Lung Transplant and Hematopoietic Stem Cell Transplant Recipients for the Treatment of Bronchiolitis Obliterans SyndromeCompletedNCT01287078Phase 2Results posted
• Extension Study (Extended Access) of Cyclosporine Inhalation Solution (CIS) in Lung Transplant and Hematopoietic Stem Cell Transplant Recipients for the Treatment of Bronchiolitis ObliteransCompletedNCT01273207Phase 2Results posted
• Palifermin in Preventing Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic CancerCompletedNCT01233921Not applicableResults posted
• Alefacept in Subjects With Steroid-Refractory Chronic Graft-versus-Host DiseaseTerminatedNCT01226420Phase 2Results posted
• Sirolimus & Mycophenolate Mofetil as GvHD Prophylaxis in Myeloablative, Matched Related Donor HCTTerminatedNCT01220297Phase 2Results posted
• Methotrexate or Pentostatin for Graft-versus-host Disease Prophylaxis in Risk-adapted Allogeneic Bone Marrow Transplantation for Hematologic MalignanciesCompletedNCT01188798Phase 3Results posted
• Atorvastatin for the Prophylaxis of Acute GVHD in Patients Undergoing Matched Sibling Allogeneic TransplantationCompletedNCT01175148Phase 2Results posted
• Rituximab for the Primary Treatment of Denovo Extensive Chronic Graft Versus Host Disease (GVHD)CompletedNCT01161628Phase 2Results posted
• Sirolimus, Tacrolimus, Thymoglobulin and Rituximab as Graft-versus-Host-Disease Prophylaxis in Patients Undergoing Haploidentical and HLA Partially Matched Donor Hematopoietic Cell TransplantationTerminatedNCT01116232Phase 2Results posted
• Histone Deacetylase Inhibitor LBH589 in Addition to Corticosteroids in Patients With Acute Graft Versus Host Disease (GVHD)CompletedNCT01111526Phase 1/2Results posted
• Chronic Graft-versus-Host Disease Treatment (BMT CTN 0801)CompletedNCT01106833Phase 2/3Results posted
• Rituximab in Preventing Acute Graft-Versus-Host Disease in a Donor Stem Cell Transplant for Hematologic CancerTerminatedNCT01044745Phase 2Results posted
• Combination of Alemtuzumab and Rituximab at Low-doses in Refractory Chronic Graft-Versus-Host DiseaseCompletedNCT01042509Not applicableResults posted
• Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)CompletedNCT01002742Phase 3Results posted
• Haploidentical PBMC Transplant for Severe Congenital AnemiasActive, not recruitingNCT00977691Phase 1/2Results posted
• Maraviroc in Patients Undergoing Non-Myeloablative Allogeneic Stem-Cell TransplantationCompletedNCT00948753Phase 1/2Results posted
• Low-Dose Prednisone or Methylprednisolone in Treating Patients With Newly Diagnosed Acute Graft-versus-Host DiseaseCompletedNCT00929695Phase 3Results posted
• Study of orBec® With Prednisone Therapy in the Treatment of Patients With Graft Versus Host Disease (GVHD)TerminatedNCT00926575Phase 3Results posted
• Low-Intensity Stem Cell Transplantation With Multiple Lymphocyte Infusions to Treat Advanced Kidney CancerCompletedNCT00923845Phase 2Results posted
• Selective Depletion of CD45RA+T Cells From Allogeneic Peripheral Blood Stem Cell Grafts for the Prevention of GVHDTerminatedNCT00914940Phase 2Results posted
• Bortezomib Plus Prednisone for Initial Therapy of Chronic Graft Versus Host DiseaseCompletedNCT00815919Phase 2Results posted
• Vorinostat to Prevent Graft Versus Host Disease Following Reduced Intensity, Related Donor Stem Cell TransplantCompletedNCT00810602Phase 1/2Results posted
• Graft-Versus-Host Disease (GVHD) Prophylaxis After Allogeneic Peripheral Blood Hematopoietic Cell TransplantationCompletedNCT00803010Phase 2Results posted
• Busulfan and Fludarabine Followed by Post-transplant CyclophosphamideCompletedNCT00800839Phase 2Results posted
• CC-4047 (Pomalidomide) for Graft vs. Host DiseaseCompletedNCT00770757Phase 2Results posted
• Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure DisorderCompletedNCT00755040Phase 3Results posted
• The Use of Etanercept Enbrel as Sole Treatment for Grade I Acute Graft Versus Host DiseaseCompletedNCT00726375Phase 3Results posted
• Visilizumab for the Prevention of Graft-versus-Host Disease After Allogeneic Hematopoietic Cell TransplantationTerminatedNCT00720629Phase 2Results posted
• Imatinib Mesylate to Treat Skin Changes in Patients With Chronic Graft-Versus-Host DiseaseCompletedNCT00702689Phase 2Results posted

← Graft vs Host Disease overview